Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes
Arctigenin (ATG) is the major active component of a Chinese herbal remedy known to reduce proteinuria in patients with diabetic kidney disease (DKD). Here, Zhong et al. identify PP2A as a pharmacological target of ATG in podocytes, and find that PP2A is responsible for some of the beneficial effects...
Guardado en:
Autores principales: | Yifei Zhong, Kyung Lee, Yueyi Deng, Yueming Ma, Yiping Chen, Xueling Li, Chengguo Wei, Shumin Yang, Tianming Wang, Nicholas J. Wong, Alecia N. Muwonge, Evren U. Azeloglu, Weijia Zhang, Bhaskar Das, John Cijiang He, Ruijie Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a5b2bbb2f2147bf8cd9959dcec76d0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Xueling Li, et al.
Publicado: (2017) -
Controversies in Podocyte Loss: Death or Detachment?
por: Lijun Yin, et al.
Publicado: (2021) -
Arctigenin efficiently enhanced sedentary mice treadmill endurance.
por: Xuan Tang, et al.
Publicado: (2011) -
Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity
por: Rhodora C. Calizo, et al.
Publicado: (2019) -
Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
por: Ming-Fo Hsu, et al.
Publicado: (2017)